Abstract
The field of Tourette’s disorder (TD) has seen a number of clinically significant developments in recent years. These include new knowledge related to tic phenomenology and management, updated management guidelines, novel insights regarding predictors of tic symptom evolution after first onset, increasing interest in cannabinoids, and the recent pervasiveness of functional tic-like behaviors. The goal of this session is to review these recent developments and discuss their clinical implications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
